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BACKGROUND: Spinal anesthesia for cesarean delivery may cause severe maternal hypotension and a decrease in
cardiac output. Compared to assessment of cardiac output via a pulmonary artery catheter, the FloTrac/Vigileo
TM
system may offer a less invasive technique. The aim of this study was to evaluate cardiac output and other
hemodynamic measurements made using the FloTrac/Vigileo
TM system in patients undergoing spinal anesthesia for
elective cesarean section.
METHODS: A prospective study enrolling 10 healthy pregnant women was performed. Hemodynamic parameters
were continuously obtained at 15 main points: admission to surgery (two baseline measurements), after preload,
after spinal anesthesia administration and 4 time points thereafter (4, 6, 8 and 10 min after anesthesia), at skin and
uterine incision, newborn and placental delivery, oxytocin administration, end of surgery, and recovery from
anesthesia. Hemodynamic therapy was guided by mean arterial pressure, and vasopressors were used as appropriate
to maintain baseline values. A repeated measures ANOVA was used for data analysis.
RESULTS: There was a significant increase in heart rate and a decrease of stroke volume and stroke volume index up
to 10 min after spinal anesthesia (P , 0.01). Importantly, stroke volume variation increased immediately after
newborn delivery (P , 0.001) and returned to basal values at the end of surgery. Further hemodynamic parameters
showed no significant changes over time.
DISCUSSION AND CONCLUSIONS: No significant hemodynamic effects, except for heart rate and stroke volume
changes, were observed in pregnant women managed with preload and vasopressors when undergoing elective
cesarean section and spinal anesthesia.
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INTRODUCTION
Cardiac output (CO) is routinely monitored in critically
ill patients with the primary goal of maintaining adequate
tissue perfusion.
1 In most patients in the surgical setting,
thermodilution using a pulmonary artery catheter (PAC) is
still the most frequently applied technique and has
generally been accepted as the clinical gold standard.
1
However, the value of the PAC has been questioned
in recent years, and its impact on outcome is controver-
sial.
1,2 More recently, several less-invasive techniques that
avoid the risks associated with the PAC have become
available for routine CO monitoring.
3,4 These devices
include continuous monitors that use arterial pressure
waveform analysis to estimate CO and other hemodynamic
parameters.
5-8
Recently, a new continuous arterial pulse-wave analysis
device that does not require external calibration, thermo-
dilution or dye dilution has become available.
9,10 The
FloTrac/Vigileo
TM system (Edwards Lifesciences, Irvine,
CA, USA) obtains the pressure wave signal from any
standard peripheral arterial line, and the standard deviation
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793of the pulse pressure is empirically correlated with the
stroke volume based on patient demographic characteristics
(age, gender, body height, and weight) after automatic
adjustment for actual vascular compliance.
9,10 Early valida-
tion studies for this device showed conflicting results.
11-13
Thus, the FloTrac/Vigileo
TM software and its underlying
algorithm were revised, and improved versions have
recently become available for clinical use.
14,15
Spinal anesthesia for cesarean delivery may cause severe
maternal hypotension and a decrease in CO and blood flow
to the placenta.
16,17 Prevention of hemodynamic instability
during cesarean delivery during spinal anesthesia has been
the aim of several studies aiming to minimize fetal and
maternal morbidity. Most studies have used noninvasive
monitoring devices to evaluate hemodynamic responses
related to spinal anesthesia in the obstetric setting.
17,18
Consequently, the actual hemodynamic responses to spinal
anesthesia for cesarean delivery (i.e., CO and systemic
vascular resistance changes) are still poorly understood,
especially in patients displaying cardiovascular disorders
such as preeclampsia. Considering the pivotal role of the
strict control of spinal anesthesia-related hemodynamic
changes in pregnant patients and the recent advances in
minimally invasive hemodynamic monitoring, this study
was designed to detect and evaluate hemodynamic
responses to delivery, vasopressors, and oxytocin in healthy
pregnant women undergoing elective cesarean section
following spinal anesthesia using the new FloTrac/
Vigileo
TM monitoring system.
METHODS
Subjects
A prospective observational study of adult pregnant
women at term was performed in a tertiary care hospital in
Brazil. The protocol was evaluated and approved by the
institution’s research and ethics committee. Written
informed consent was obtained from all patients. In this
study, 10 consecutive healthy pregnant women were
enrolled with ages ranging from 18 to 25 years. Exclusion
criteria were as follows: patient refusal, patients younger
than 18 years, chronic arterial hypertension, twin preg-
nancy, active labor, heart or pulmonary disease, preopera-
tive dysrhythmias, cognitive impairment or difficulty in
understanding verbal commands, or presentation with
absolute or relative contra-indications to regional anesthe-
sia. All patients underwent preoperative transthoracic
echocardiography, and no valvular dysfunctions were
documented. Patients displaying reduced ventricular func-
tion or signs of pulmonary artery hypertension were also
excluded.
Anesthesia procedure and CO monitoring
Antepartum management, anesthesia and postoperative
management followed institutional standards. Patients
received no premedication. In the operating room, routine
monitoring was applied (Philips IntelliVue
TM Monitoring,
Philips Medical Systems, Andover, MA, USA), including
pulse oximetry and 5-lead electrocardiography, and a 16-G
catheter was inserted into right cephalic vein. Routine access
to the left radial artery was established and connected to the
Vigileo
TM monitor (Edwards Lifesciences, Irvine, CA; soft-
ware version 1.07) via the FloTrac
TM pressure transducer.
Patient data (age, gender, body weight, and height) were
entered, and after checking the arterial line waveform
fidelity, the system was zeroed and CO measurement
initiated. The CO was recorded continuously during the
perioperative period. Intravenous crystalloid preload (lac-
tated Ringer’s solution, 10 ml/kg
21) was rapidly infused
and initiated immediately before lumbar puncture. No
further fluids were administered unless excessive hemor-
rhaging occurred. All patients received 10 mg (2 ml)
hyperbaric 0.5% bupivacaine plus 15 mg fentanyl and 80 mg
morphine sulfate administered at the L3–L4 interspace using
a 27-G Whitacre needle. After spinal anesthesia, patients
were in the supine position with 20˚ of left lateral tilt
throughout the entire study period to minimize aortocaval
compression. Block height was assessed using cold sensi-
tivity to 70% ethanol solution. All patients received
supplemental oxygen by nasal catheter until delivery.
The FloTrac/Vigileo
TM system needs no external calibra-
tion and provides continuous cardiac output measurements
from the arterial pressure wave. The Vigileo
TM (Software
version 1.07) records hemodynamic variables at 20-s
intervals and performs calculations on the most recent 20 s
of data. The system calculates the stroke volume (SV) using
arterial pulsatility (standard deviation of the pulse pressure
over a 20-s interval), resistance, and compliance. The CO is
calculated as follows: CO = heart rate 6 SV [SV = K 6
pulsatility]. K is a constant that represents arterial com-
pliance and vascular resistance and is derived from a
multivariate regression model. The rate of adjustment of K
was 1 min (Software 1.07). Pulsatility is proportional to the
standard deviation of the arterial pressure wave over a 20-s
interval.
Study protocol
Hemodynamic measurements included recordings of
heart rate, mean arterial pressure (MAP), central venous
pressure (CVP), cardiac output (CO), cardiac index (CI),
stroke volume (SV), stroke volume index (SVI), stroke
volume variation (SVV), and systemic vascular resistance
(SVR). All hemodynamic data were recorded by an observer
not involved in the routine management of the patient at
predefined time points. Hemodynamic parameters were
continuously obtained and analyzed at 15 main time points:
admission to the surgery room (two baseline measurements
regarding dorsal and lateral position – T0 and T1), after a
volume preload of lactated Ringer’s solution 10 ml/kg
21
(T2), immediately after spinal anesthesia administration (T3)
and 4 time points thereafter (4, 6, 8 and 10 min after spinal
anesthesia – T4 through T7), during skin incision (T8),
uterine incision (T9), newborn delivery (T10), placental
delivery (T11), immediately after oxytocin administration
(T12), end of surgery (T13), and at recovery from spinal
anesthesia (T14). Systemic vascular resistance was calculated
according to the following formula: systemic vascular
resistance = (MAP 2 CVP) 6 79.9/CO. Hemodynamic
therapy was guided by MAP values, and vasopressors
(metaraminol) were used as appropriate to maintain base-
line arterial pressure values. The MAP value for the
purposes of calculation of target blood pressures for
vasopressor administration was recorded as the mean of
three consecutive readings not differing from one another
by more than 10% and taken before sitting up for the
induction of anesthesia. If MAP decreased by up to 20%
from baseline, a bolus of metaraminol 0.2 mg was
administered every minute to maintain MAP within 20%
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794of the baseline value. If MAP decreased by more than 20%
from baseline, a bolus of metaraminol 0.4 mg was
administered every minute until the blood pressure
recovered to within 20% of baseline.
Further interventions were as follows: immediately after
delivery, 2-U oxytocin diluted in 10 ml saline solution was
intravenously administered over a period of 60 s.
Thereafter, a separate infusion of 20-U oxytocin in saline
solution was started at 5 U/h
21 over 4 hours. Intravenous
cefazolin (2 g) was slowly administered immediately after
umbilical cord clamping. Intraoperative maternal blood loss
was estimated from suction bottle measurement and
checking of swabs at the end of the procedure.
Statistical analysis
Data were stored in EPI-INFO (software version 6.0) and
analyzed by Statistical Package for the Social Sciences (SPSS)
(version 15.0) for Windows (registered trademark). All data
are expressed as means ¡ standard error of the mean (SEM)
unless otherwise stated. Data were submitted to
Kolmogorov-Smirnov and Bartlett tests for normality
evaluation. Hemodynamic variables for each time interval
were compared with the baseline by analysis of variance
(ANOVA) for repeated measurements. If the ANOVA
revealed a significant interaction, post hoc analysis was
performed using the Bonferroni multiple comparisons test
when applicable. P , 0.05 was considered to represent a
statistically significant difference.
RESULTS
Ten consecutive pregnant women with a mean age of
22.4 years (range 18–25 years), a body mass index (BMI) of
29.4 ¡ 4.1 kg/m
22, and a body surface area (BSA) of 1.65 ¡
0.06 kg/m
22 as well as preserved left ventricular function
and sinus rhythm who were undergoing elective cesarean
section were enrolled. All patients completed the study and
underwent uneventful surgical procedures, achieving a
maximum block height at the T4 dermatome level. There
were no block failures, and no patients displayed blood loss
greater than 500 ml. The mean surgery time was 75 ¡
12 min, and the measurement period was uneventful for all
patients. A total of 8 of 10 patients received metaraminol for
MAP restoration; the mean total dose of metaraminol was
1.6 ¡ 0.2 mg/patient.
Table 1 displays the average hemodynamic data at the
defined time intervals. Cardiac output and cardiac index
remained stable throughout the procedure and after
recovery from spinal anesthesia (P = 0.24 and 0.25,
respectively). There was a significant increase in HR and a
decrease of SV and SVI up to 10 min after spinal anesthesia
(P , 0.01). Importantly, the SVV increased immediately
after newborn delivery (P , 0.001) and returned to basal
values at the end of surgery. However, no significant effects
on CVP (P = 0.09) or SVR were observed (P = 0.75). Mean
arterial pressure assessed by FloTrac/Vigileo
TM system also
showed no significant changes over time (P = 0.08).
DISCUSSION
This observational study describes maternal hemody-
namic responses to spinal anesthesia for cesarean delivery
in 10 healthy women, evaluated using the FloTrac/
Vigileo
TM system. This study demonstrated that spinal
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795anesthesia was associated with hemodynamic stability in
obstetric patients undergoing cesarean section, as no
significant hemodynamic effects (except for heart rate and
stroke volume changes) were observed in pregnant women
managed with crystalloid preload and vasopressors.
Additionally, we demonstrated that the FloTrac/Vigileo
TM
system is a reliable method for monitoring hemodynamic
responses to spinal anesthesia in pregnant patients,
although it should be compared to other methods in future
studies. This minimally invasive device designed to
measure CO- and SV-related parameters may be considered
to further improve hemodynamic control and outcomes in
obstetric anesthesia.
Monitoring of cardiac performance is important to either
confirm diagnosis or guide therapy in patients undergoing
major surgery or critically ill patients in the intensive care
unit.
1 The invasive technique of pulmonary artery catheter-
ization has been used to optimize hemodynamics.
1,2
Recently, less-invasive devices to measure CO have become
available. These techniques include transthoracic bioimpe-
dance, pulse dye densitometry, esophageal Doppler, trans-
esophageal echocardiography and arterial pulse-wave
analysis. Methods based on pulse-wave analysis have
become increasingly accepted and gradually introduced
into clinical practice.
5-10 Commercially available devices
include the PiCCOsystem (PiCCO
TM, Pulsion Medical
Systems) and the LiDCO-system (LiDCO
TM, LiDCO Ltd.),
which both require invasive calibration by either transpul-
monary thermodilution or lithium dilution after a certain
time to compensate for interindividual differences in
vascular compliance.
19 The FloTrac/Vigileo
TM system offers
the possibility of uncalibrated, continuous CO measure-
ments on the basis of arterial waveform analysis combined
with simple usability. In this study, we used the software
version 1.07, which records hemodynamic variables at 20-s
intervals. More recent software versions have improve-
ments consisting of more frequent recalculation of an
internal variable estimating vascular tone combined with a
reduction of pulse-wave detection noise. Notably, this study
was designed to evaluate the ability of the FloTrac/
Vigileo
TM system to detect hemodynamic variations during
cesarean section procedures under spinal anesthesia and to
speculate about the main mechanisms involved in these
hemodynamic changes. Considering these goals and the
regular use of non-invasive hemodynamic monitoring
methods for pregnant women undergoing cesarean section,
we did not compare the FloTrac/Vigileo
TM system to gold
standards such as the pulmonary artery catheter or
transesophageal echocardiography.
The optimal anesthetic technique and hemodynamic
monitoring for cesarean delivery in both healthy patients
and women displaying cardiovascular diseases such as
preeclampsia still remains controversial.
20,21 Most studies
have focused on changes in blood pressure and heart rate as
the key hemodynamic variables representing maternal CO
during spinal anesthesia for cesarean delivery.
22,23
Although heart rate and blood pressure measurements are
of significant value in assessing the safety of an anesthetic
technique, the true goal of spinal anesthesia for cesarean
delivery is to maintain maternal CO and uteroplacental
blood flow. In healthy patients, the maximum change in CO
has been shown to correlate better to uteroplacental blood
flow than to upper arm blood pressure.
24 More recently,
Dyer et al.
17 tested the hypothesis that continuous monitor-
ing of CO in patients with severe preeclampsia during
spinal anesthesia for cesarean delivery would give better
information on the uteroplacental blood flow than determi-
nation of the mean radial artery blood pressure. It was
found that CO, as inferred from pulse-wave analysis, did
not decrease significantly from baseline if the mean radial
artery blood pressure was maintained at baseline levels with
intermittent vasopressors; therefore, it was concluded that
spinal anesthesia was associated with clinically insignificant
changes in CO. The study by Dyer and colleagues
17 used the
LiDCO
TM system, a method based on aortic pulse-wave
analysis, to examine rapid changes in cardiovascular
variables associated with spinal anesthesia, vasopressors,
and oxytocin during cesarean section. However, this
method of CO assessment has not been recommended
during hemodynamic instability and has been shown to
produce CO assessment errors during cardiac surgery.
25
Notably, none of the above waveform-related methods
(FloTrac/Vigileo
TM or LiDCO
TM system) are validated for
evaluation of hemodynamic changes during spinal anesthe-
sia and cesarean delivery. The results of these techniques
with respect to reproducibility and accuracy are not
uniform.
11-13,19 Whether they can guide therapy better than
routine measurement of blood pressure remains to be
determined. These additional methods for continuous
monitoring of CO may herald a new era in which we focus
on blood flow instead of blood pressure as the key
hemodynamic variable in obstetric anesthesia.
26 This will
provide more information and ultimately a better under-
standing of the hemodynamic changes in pregnant women
and spinal anesthesia-related hemodynamic responses. The
acquisition of such knowledge may improve our manage-
ment with respect to the choice of fluids and vasopressors.
27
Pulse-wave analysis has been used in careful investiga-
tions of cardiovascular responses during pregnancy. The
first cardiovascular alteration during pregnancy is the
increase in arterial compliance that starts in the first
trimester.
23 Additionally, peripheral vascular resistance
decreases moderately throughout gestation, followed by
an increase in CO, HR, SV and aortic distensibility, a
decrease in peripheral vascular resistance and an increase in
left ventricular wall thickness from the second trimester to
the end of pregnancy.
28 Notably, Dyer et al.
17 found that CO
remained stable throughout cesarean delivery, except for in
the period after oxytocin bolus administration (2.5 U). In the
present study, however, no significant effects regarding CO
or other hemodynamic parameters (except for SVV) were
observed after oxytocin administration. The response to
oxytocin observed by Dyer et al.
17 was more pronounced
than that observed in a recent protocol using thoracic
bioimpedance, in which a high-dose oxytocin regimen was
used (5 or 10 U oxytocin administered as a rapid bolus).
29
Therefore, it is tempting to speculate that these differences
may be related to the low-dose and/or slow-infusion
oxytocin regimen used in the present protocol or even to
the absence of cardiovascular comorbidities. Considering
that oxytocin may cause transient profound hypotension
and tachycardia
17 and that the ED95 for oxytocin in elective
cesarean section has been shown to be around 0.35 U,
30
consideration should be given to administering this drug by
slow, titrated, and diluted intravenous infusion.
In the present study, there was a significant decrease of
SV and SVI after spinal anesthesia. However, this effect was
likely physiologically compensated by an increase in HR.
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796Central venous pressure, SVR and MAP showed no
significant changes over time. These results were not
compared to previous LiDCO
TM results in women display-
ing preeclampsia, where both MAP and SVR decreased
significantly from the time of the adoption of the supine
position until the end of surgery. Consequently, in the study
by Dyer and colleagues
17, spinal anesthesia was associated
with significant afterload reduction and minimal CO
changes. We speculate that our results may be related to a
prompt and more effective correction of MAP values by
application of the vasopressor metaraminol, which ulti-
mately produced CO maintenance throughout the proce-
dure. Although vasopressors such as metaraminol and
phenylephrine (a1-agonists), rather than ephedrine, have
been recommended for treating spinal anesthesia-related
hypotension,
31 further studies are required to establish,
from both the maternal and fetal points of view, the best
agent to restore maternal MAP. A recent study showed that
a bolus of phenylephrine reduced maternal CO and
decreased CO to a greater extent than ephedrine during
elective spinal anesthesia for cesarean delivery.
32
Interestingly, CO changes were correlated with heart rate
changes after vasopressor administration, emphasizing the
importance of heart rate as a surrogate indicator of CO.
However, phenylephrine was more effective than ephedrine
for counteracting hemodynamic responses to oxytocin.
32
Future studies should address these issues using waveform
analysis combined with methods for observation of uter-
oplacental perfusion.
Fluid response prediction is difficult in spontaneously
breathing patients. Because the swings in intrathoracic
pressure are minor during spontaneous breathing, hemo-
dynamic parameters like SVV are usually small.
31 However,
in the present study, the SVV increased immediately after
newborn delivery and returned to basal values at the end of
surgery. Notably, in spontaneously breathing, hemodyna-
mically unstable patients, Soubrier et al.
33 found a sensitiv-
ity and specificity of 47% and 92%, respectively, for
predicting fluid responsiveness for SVV. However, emer-
ging data suggest that the application of some measures
such as forceful inspiration and expiration, Valsalva
maneuvers or expiratory resistors are capable of magnifying
the ability of SVV to predict fluid responsiveness.
31,34 It
remains unclear whether optimized methods to measure
SVV could be of value for prediction of fluid responsiveness
in the obstetric setting, and new studies are thus warranted.
In summary, this study provides additional evidence that
the FloTrac/Vigileo
TM system can be used for CO measure-
ment as it was consistent when tested in patients under-
going spinal anesthesia in an obstetric setting. To our
knowledge, this study is the first to test this pulse-wave
analysis method in an obstetric setting. No significant
hemodynamic effects (except for heart rate and stroke
volume changes) were observed in pregnant women
managed with crystalloid preload and vasopressors under-
going elective cesarean section and spinal anesthesia. New
studies addressing the monitoring of cardiac output and
stroke volume parameters with respect to outcomes in
obstetric patients are warranted. A better understanding of
perioperative hemodynamic responses in obstetrics may
contribute to a significant reduction in maternal and
neonatal morbidity. The use of minimally invasive
methods such as the FloTrac/Vigileo
TM system in pregnant
women presenting with significant cardiovascular disorders
should be considered and could be a main target for future
studies.
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